Acute Rhinosinusitis {#Sec1}
====================

Acute rhinosinusitis (ARS) is the inflammation of the nasal mucous membrane and can be separated into acute viral and acute bacterial rhinosinusitis. It is frequently observed after viral rhinitis or common cold \[[@CR1]\].

Viral ARS {#Sec2}
---------

Viral, post-viral, and acute bacterial ARS (ABRS) display significantly similar clinical presentation and inflammatory mechanism. Viral infection of the sinus cavity can cause numerous changes such as post-viral inflammation and epithelial damage, which enhance the susceptibility to bacterial infection \[[@CR1]\].

The most common virus families that cause ARS are coronavirus and rhinovirus. Approximately 50% of common colds are caused by the human rhinovirus. Other viral offenders include parainfluenza, influenza, respiratory syncytial virus (RSV), adenovirus, and enterovirus \[[@CR2]\].

Common Bacteria in ABRS {#Sec3}
-----------------------

ABRS is generally accompanied by a viral upper respiratory tract infection. Multiple factors can predispose a person to bacterial infection by damaging normal mucociliary clearance such as allergy/inflammatory diseases, environmental factors, dental infection, and anatomic variation among others \[[@CR3]\].

The most widely recognized bacteria in ABRS are *S. pneumonia*, *H. influenza*, and *M. catarrhalis* and *S. aureus*, while other species and anaerobic bacteria may also contribute to the infection \[[@CR4]--[@CR6]\]. Interestingly, Payne and colleagues performed a meta-analytic study on reports about the microbiology of ABRS, which evaluated the most common bacterial occurrence within the sinus. The report showed that the maxillary sinus contained *H. influenza*, *S. pneumoniae*, *M. catarrhalis*, and *S. aureus* at 28%, 26%, 6%, and 8%, respectively. On the other hand, the same bacteria were found at 34%, 29%, 11%, and 14%, respectively, in the middle meatus \[[@CR4]\]. Furthermore, Brook and Gober \[[@CR7]\] showed that *S. pneumoniae* decreased from 44 to 27%, while *H. influenza, S. pyrogenes,* and *S. aureus* increased from 37 to 44%, from 7 to 12%, and from 4 to 8%, respectively, with no change in *M. catarrhalis* (from 13 to 14%). These findings were determined from nasopharyngeal cultures taken from children before and after administration of a pneumococcal conjugate vaccine.

*S. aureus* is commonly associated with the pathogenesis of sphenoid sinusitis. The 7-valent pneumococcal vaccine was presented in the United States in 2000 and aided in the reduction of the recovery rate for *S. pneumoniae* and the increase in the rate of *H. influenza* \[[@CR7], [@CR8]\]*.* Additionally, the recovery rate against *S. pneumoniae* antibiotic-resistant strains was found to be diverse after vaccination.

Other gram-negative bacteria, including *P. aeruginosa,* have been determined to associate with nosocomial origin acute sinusitis, immunocompromised patients, and cystic fibrosis \[[@CR3]\].

Approximately 66% of acute sinusitis patients were shown to have at least one pathogenic bacteria species within the sinus aspirates, while the others had multiple bacterial species. The bacteria associated with acute sinusitis colonized the normal nasal flora. Interestingly, these become pathogenic when they accumulate in the sinus \[[@CR3]\].

Although the environment is sufficient and available for their growing, *S. pyogenes, S. aureus,* and other anaerobes are not as common with ABRS, and have been found in less than 10% of ABRS patients. Sinusitis that results from dental infection or chronic manifestations are the exceptions \[[@CR3]\].

A study performed in 1998 on respiratory tract/paranasal sinuses isolates showed that 12.3% of *S. pneumoniae* were marginally resistant to penicillin, while 37.4% fully resistant. Interesting to note, the paranasal sinuses had the highest rate of resistance for bacteria isolated from that region \[[@CR9]\]. Also, the resistance to trimethoprim-sulfamethoxazole, clindamycin, macrolide, and doxycycline was more common in with the bacteria with intermediate penicillin resistance. *H. influenzae* may be encapsulated or unencapsulated. The type B form was a marginal contributor to meningitis before the incorporation of the vaccine. Unencapsulated strains contribute to 22--35% of ABRS in adults. One of the biggest contributors to antimicrobial resistance is the beta-lactamase production in the organism*.* Interestingly, 32.7--44% of the isolates from the paranasal sinus were determined to be *H. influenza* beta-lactamase positive \[[@CR3]\].

*M. catarrhalis* bacteria are responsible for 2--10% of the ABRS adult cases. Beta-lactamase also contributes to the antibiotic resistance in *M. catarrhalis*, in which 98% of the isolates from the paranasal sinus were beta-lactamase positive \[[@CR3]\].

To date, *S. aureus* accounts for 10% of ABRS episodes, but is becoming a common pathogen in ABRS \[[@CR10]\]. While MRSA (methicillin-resistant *S. aureus*) still contributes to a few rhinosinusitis episodes, growing developments in *S. aureus* drug-resistance may change our treatment strategies in the future \[[@CR11]\].

Gram-negative organisms such as *P. aeruginosa*, *E. coli*, *P. mirabilis*, *K. pneumoniae,* and the Enterobacter species have been noticeable in the nosocomial sinusitis, which accounts for 60% of the known cases. Gram-positive organisms (31%) and fungi (8.5%) make up the other pathogens responsible for nosocomial infection \[[@CR3]\]. Polymicrobial invasion has been observed in 25--100% of isolates.

Chronic Rhinosinusitis (CRS) in the Absence or Presence of Nasal Polyps (CRSwNP or CRSsNP) {#Sec4}
==========================================================================================

CRSwNP and CRSsNP are composed of many forms and are common conditions in medicine \[[@CR1]\].

Inflammatory Triggers {#Sec5}
---------------------

### Viruses {#Sec6}

Viruses are a source of CRS. They can integrate into host DNA and cause infection in the mucosa of the upper lungs. A previous report demonstrated that the rhinovirus was found in 21% of epithelial cell specimens of CRS patients compared to none in the control cells \[[@CR12]\]. Conversely, another study failed to confirm this finding and showed that no viruses were found in either group \[[@CR13]\]. Altogether, these data do not indicate a role for virus infection and chronic inflammation in CRS.

The known mechanism that triggers virus-first event predisposing to the improvement of CRS is also lacking. Interestingly, viral infections at an early age have been connected to asthma, though this idea has not been proven in CRS \[[@CR14]\]. It is believed that virus-induced epigenetic changes may occur in the host during the life development \[[@CR15]\].

### CRS Nasal and Sinus Microbiota {#Sec7}

To date, microbiota analysis of the nasal and sinus from CRS patients has been performed using standard lab techniques. *S. epidermidis* levels were found to be higher in controls when compared to CRS \[[@CR16]\]. Upon comparison of ARS and CRS, there was a greater increase in the levels of gram-negative rods, *S. aureus*, and anaerobes in CRS \[[@CR17]--[@CR25]\]. Moreover, other researchers determined that there was no difference between the bacteriology of CRS nasal and normal nasal swabs \[[@CR26], [@CR27]\]. Similar microbiological flora was observed for the infected and non-infected sides in cases of unilateral CRS \[[@CR28]\]. In addition, the results of the culture were similar upon a successful sinus surgery \[[@CR29]\]. All in all, these reports confirmed the bacterial role in the CRS pathogenesis. Although, a few of the differences were most likely due to the discrepancies in the procedures \[[@CR17]\], associated allergic rhinitis \[[@CR30]\], prior antibiotic administration and source of material (sinus or nasal). Interestingly, a few researchers neglect the role of *S. epidermidis*. The occurrence of organisms within epithelial cells \[[@CR31], [@CR32]\] or in biofilm possibly produce differences in the bacterial identification rate with traditional methods.

The bacteria in CRS vary in comparison to ARS. Bacteria have been recorded in many samples acquired by endoscopy or sinus puncture in CRS patients \[[@CR33]\].*Staphylococcus aureus* (both MSSA and MRSA) \[[@CR11]\]Staphylococci (coagulase-negative) (SCN)*H. influenzaeM. catarrhalisS. pneumoniaeS. intermediusP. aeruginosaN.* speciesother anaerobic bacteria \[[@CR34], [@CR35]\]

The exact role(s) of all microbes in the etiology of CRS are ambiguous in contrast to that of ARS. Numerous researchers are divided on the microbial etiology of CRS. The biggest difference may lie in the methods or techniques used. Multiple reports have shown that their methods for the anaerobe recovery are key (yield 50--70% of samples) \[[@CR35]\]. In specimens analyzed in the studies, variability in microbial growth may also be caused by exposure to various broad-spectrum antibiotics in patients.

Jyonouchi and colleagues effectively induced CRS in rabbits by intrasinus inoculation of *B. fragilis.* Interestingly, they identified immunoglobulin G (IgG) antibodies and no *B. fragilis* in this organism \[[@CR36]\]. This is consistent with previous reports that have identified IgG antibodies against anaerobic organisms in patients with CRS \[[@CR37]\].

Microbiological reports of CRS regularly established that the infection was polymicrobial \[[@CR34]\].

In some cases, the baseline CRS suddenly worsened or induced new symptoms. This acute exacerbation of CRS was found to be polymicrobial in many cases, with the anaerobic bacteria prevailing. Nevertheless, aerobic bacteria that are typically connected with ARS may appear \[[@CR38]\].

Gram-negative facultative and aerobic bacteria have been more readily determined in CRS patients that underwent endoscopic sinus surgery \[[@CR39]\].

*S. aureus* is the most commonly found bacteria in CRS patients in the western civilization \[[@CR40]\]. Interestingly, its occurrence was shown to be much lower in Asian CRSwNP \[[@CR41]\], but the microbial abundance did not command or eliminate its role in the pathogenesis. Host proof of bacteria-specific effects exists for *S. aureus*. This suggests a role in the pathogenesis at least in a subgroup of CRSwNP patients. Substantial evidence concerning this organism in CRSwNP has accrued over the last ten years. This has brought about the "Staphylococcal Super-antigen Hypothesis," which states that *S. aureus* secretes super-antigenic toxins (SAgs) that augment local inflammation and polyps \[[@CR42], [@CR43]\].

Antimicrobial Resistance {#Sec8}
========================

Antibiotic resistance is a worldwide medical issue. Despite the beneficial technological advances, the improvement of new antimicrobial agents is currently moderate. Approximately all the developing countries are accepting a strategy to cut off and prevent antibiotic resistance by a complicated approach to improve public health. Since the most important reason of bacterial resistance is the misuse of these agents, the strategy should address the rational prescription of antibiotics. Planning nationwide antibiotic restriction programs can efficiently decrease the antibiotic-resistance rate \[[@CR44]\].

Coagulase-negative *Staphylococcus* and *S. aureus* were the most frequently found gram-positive aerobes in patients with CRS, while *H. influenzae* and *P. aeruginosa* were frequently found in gram-negative aerobes. Though the precise role of these pathogens in the pathophysiology remains to be explained, they are often cultured in CRS patients and may be important as disease modifiers. Mainly, the foundation of the precise microbiology of CRS derived from endoscopic cultures is necessary to bring about accurate antimicrobial therapy. This is particularly important given the antibiotic resistance concerns in uncontrollable patients \[[@CR45]\].

The growth of antibiotic resistance in ARS and CRS has been previously described. Hsu and colleagues \[[@CR20]\] examined the bacteriology of outpatient CRS and compared the antimicrobial sensitivities of the bacteria with standard culture data. From March to August 1994, 113 new outpatients presented with CRS. A total of 34 patients had endoscopy-directed aerobic culture in the sinus cavity. Of the 48 cultures, 43 positive cultures yielded 72 isolates. The most commonly isolated organisms were SCN (28%), *P. aeruginosa* (17%), and *S. aureus* (13%). SCN, *P. aeruginosa*, and *Pneumococcus* showed an enhanced antibiotic resistance when compared to non-urinary isolates. Also, 3 of the 6 patients with *P. aeruginosa* (50%) were resistant to quinolone. These data suggest that patients with CRS have an enhanced susceptibility to antimicrobial resistance.

In clinical settings, broad-spectrum empirical antibiotics are frequently used. But, using these broad-spectrum antibiotics regardless of the type of specific pathogenic agents can cause increased bacterial resistance and virulence. The penicillin group is a sensible first-line antibiotic for the treatment of sinusitis in many geographic areas \[[@CR46]\]. When first-line agents fail or there is a high prevalence of β-lactamase resistance, second or third-generation cephalosporins as well as quinolones supply broader coverage \[[@CR46]\]. Nevertheless, because of the wide distribution of bacterial resistance to these agents, limiting the inappropriate use of these antibiotics has been strongly considered \[[@CR44]\].

Bhattacharyya and Kepnes \[[@CR47]\] carried out a cross-sectional evaluation of a prospective database in hopes of determining the present incidence and transient patterns of antimicrobial resistance in CRS. In adults with CRS, a microbiological database was retrospectively analyzed to remove all endoscopic obtained paranasal sinus cultures from 2001 to 2005. They studied 701 bacterial cultures among 392 isolates. *S. aureus* was the most common organism (19.0%) isolated. Antibiotic resistance increased dramatically for erythromycin in the study (69.7% in 2005, *p* = 0.009), and remained unchanged or trended downward for other antibiotics used (*p* = 0.366 to *p* = 0.397201 or *p* = 0.180 and *p* = 0.120). Nineteen percent of *S. aureus* bacteria were found to be MRSA. However, MRSA-specific antibiotic resistance rates were not changed over the study (all *p* ≥ 0.222). The MRSA bacteria showed a statistical and significant increase in the rate of resistance for each antibiotic tested compared to non-MRSA. Collectively, they concluded that antibiotic resistance was developing for erythromycin at a higher rate than the other antibiotics. MRSA preserves a substantial occurrence in CRS with an associated level increase for antibiotic resistance.

Correctly obtained bacterial isolates and local antibiotic resistance patterns should guide the decision of antimicrobial treatment. The common recovery of anaerobes (often β-lactamase positive) and of MRSA in chronic maxillary sinusitis recommends the use of antimicrobial agents that are effective for the treatment of these organisms \[[@CR48]\].

In the last years, sinusitis has become a challenge and choosing the precise antimicrobial agent has become more complex. This is most likely because the predominant bacterial pathogens have grown resistant to the commonly used antibiotics \[[@CR49]\].

Three major mechanisms of resistance to penicillin are \[[@CR49]\]:"Blockage" of porin channelsBeta-lactamase productionAlteration in the penicillin-binding protein site

Beta-Lactamase {#Sec9}
--------------

Beta-lactamase producing bacteria (BLPB) in sinusitis.One-third of ARS or CRS had BLPB isolation.In infection, BLPB protects against penicillin in vitro and in vivo."Shielding" and beta-lactamase activity were shown in ARS and CRS. Antimicrobial therapy administration for the eradication of BLPB \[[@CR49]\].Oral antimicrobial agents against aerobic BLPB in ARS.Oral agents against BLPB in CRS are a combination of amoxicillin and clavulanic acid, clindamycin, and metronidazole (effective only against anaerobes) \[[@CR49]\].

*Streptococcus pneumoniae* Resistance {#Sec10}
-------------------------------------

*S. pneumonia,* penicillin resistance, and variation in penicillin-binding proteins.The national rate of resistance is over 35% of all isolates.To date, penicillin-resistant strains are 66% highly resistant.Penicillin-resistant strains are generally resistant to other antibiotics \[[@CR49]\].

Risk Factors for Infection Due to Antimicrobial-Resistant Bacteria {#Sec11}
------------------------------------------------------------------

Bacterial resistance to antibiotics has increased steadily over the years. Several factors can account for the increased resistance including prophylaxis, daycare, seasons, hospitalization, infection, communicable resistance, and/or family history of smoking \[[@CR49]\].
